L. V. Anderson and K. Davison, Multiplex Western blotting system for the analysis of muscular dystrophy proteins, Am J Pathol, vol.154, pp.1017-1039, 1999.

L. V. Anderson, K. Davison, J. A. Moss, C. Young, M. J. Cullen et al., Dysferlin is a plasma membrane protein and is expressed early in human development, Hum Mol Genet, vol.8, pp.855-61, 1999.

M. Aoki, J. Liu, I. Richard, R. Bashir, S. Britton et al., Genomic organization of the dysferlin gene and novel mutations in Miyoshi myopathy, Neurology, vol.57, pp.271-279, 2001.

Z. Argov, M. Sadeh, K. Mazor, D. Soffer, E. Kahana et al., Muscular dystrophy due to dysferlin deficiency in Libyan Jews. Clinical and genetic features, Brain, vol.123, pp.1229-1266, 2000.

R. Bashir, S. Britton, T. Strachan, S. Keers, E. Vafiadaki et al., A gene related to Caenorhabditis elegans spermatogenesis factor fer-1 is mutated in limb-girdle muscular dystrophy type 2B, Nat Genet, vol.20, pp.37-42, 1998.

S. Britton, T. Freeman, E. Vafiadaki, S. Keers, R. Harrison et al., The third human FER-1-like protein is highly similar to dysferlin, Genomics, vol.68, pp.313-334, 2000.

R. Cagliani, F. Fortunato, R. Giorda, C. Rodolico, M. C. Bonaglia et al., Molecular analysis of LGMD-2B and MM patients: identification of novel DYSF mutations and possible founder effect in the Italian population, Neuromuscul Disord, vol.13, pp.788-95, 2003.

D. B. Davis, A. J. Delmonte, C. T. Ly, and E. M. Mcnally, Myoferlin, a candidate gene and potential modifier of muscular dystrophy, Hum Mol Genet, vol.9, pp.217-243, 2000.

I. Illa, C. Serrano-munuera, E. Gallardo, A. Lasa, R. Rojas-garcia et al., Distal anterior compartment myopathy: a dysferlin mutation causing a new muscular dystrophy phenotype, Ann Neurol, vol.49, pp.130-134, 2001.

S. N. Illarioshkin, I. A. Ivanova-smolenskaya, C. R. Greenberg, E. Nylen, V. S. Sukhorukov et al., Identical dysferlin mutation in limb-girdle muscular dystrophy type 2B and distal myopathy, Neurology, vol.55, pp.1931-1934, 2000.

K. Kawabe, K. Goto, I. Nishino, C. Angelini, and Y. K. Hayashi, Dysferlin mutation analysis in a group of Italian patients with limb-girdle muscular dystrophy and Miyoshi myopathy, Eur J Neurol, vol.11, pp.657-61, 2004.

W. H. Linssen, N. C. Notermans, Y. Van-der-graaf, J. H. Wokke, P. A. Van-doorn et al., Miyoshi-type distal muscular dystrophy. Clinical spectrum in 24 Dutch patients, Brain, vol.120, pp.1989-96, 1997.

J. Liu, M. Aoki, I. Illa, C. Wu, M. Fardeau et al., Dysferlin, a novel skeletal muscle gene, is mutated in Miyoshi myopathy and limb girdle muscular dystrophy, Nat Genet, vol.20, pp.31-37, 1998.

I. Mahjneh, G. Marconi, K. Bushby, L. V. Anderson, H. Tolvanen-mahjneh et al., Dysferlinopathy (LGMD2B): a 23-year follow-up study of 10 patients homozygous for the same frameshifting dysferlin mutations, Neuromuscul Disord, vol.11, pp.20-26, 2001.

C. Matsuda, M. Aoki, Y. K. Hayashi, M. F. Ho, K. Arahata et al., Dysferlin is a surface membraneassociated protein that is absent in Miyoshi myopathy, Neurology, vol.53, pp.1119-1141, 1999.

E. M. Mcnally, C. T. Ly, H. Rosenmann, S. Mitrani-rosenbaum, W. Jiang et al., Splicing mutation in dysferlin produces limb-girdle muscular dystrophy with inflammation, Am J Med Genet, vol.91, pp.305-317, 2000.

M. Nakagawa, T. Matsuzaki, M. Suehara, N. Kanzato, H. Takashima et al., Phenotypic variation in a large Japanese family with Miyoshi myopathy with nonsense mutation in exon 19 of dysferlin gene, J Neurol Sci, vol.184, pp.15-24, 2001.

P. C. Ng and S. Henikoff, Predicting deleterious amino acid substitutions, Genome Research, vol.11, pp.863-74, 2001.

R. Pogue, L. V. Anderson, A. Pyle, C. Sewry, C. Pollitt et al., Strategy for mutation analysis in the autosomal recessive limb-girdle muscular dystrophies, Neuromuscul Disord, vol.11, pp.80-87, 2001.

A. Saito, I. Higuchi, M. Nakagawa, M. Saito, K. Hirata et al., Miyoshi myopathy patients with novel 5' splicing donor site mutations showed different dysferlin immunostaining at the sarcolemma, Acta Neuropathol (Berl), vol.104, pp.615-635, 2002.

, Molecular cloning. A laboratory manual, 1989.

K. Tagawa, M. Ogawa, K. Kawabe, G. Yamanaka, T. Matsumura et al., Protein and gene analyses of dysferlinopathy in a large group of Japanese muscular dystrophy patients, J Neurol Sci, vol.211, pp.23-31, 2003.

T. Takahashi, M. Aoki, M. Tateyama, E. Kondo, T. Mizuno et al., Dysferlin mutations in Japanese Miyoshi myopathy: relationship to phenotype, vol.60, pp.1799-804, 2003.

H. Ueyama, T. Kumamoto, H. Horinouchi, S. Fujimoto, H. Aono et al., Clinical heterogeneity in dysferlinopathy, Intern Med, vol.41, pp.532-538, 2002.

M. C. Walter, C. Braun, M. Vorgerd, M. Poppe, C. Thirion et al., Variable reduction of caveolin-3 in patients with LGMD2B/MM, Journal of neurology, vol.250, pp.1431-1469, 2003.

T. Weiler, R. Bashir, L. V. Anderson, K. Davison, J. A. Moss et al., Identical mutation in patients with limb girdle muscular dystrophy type 2B or Miyoshi myopathy suggests a role for modifier gene(s), Hum Mol Genet, vol.8, pp.871-878, 1999.